Examkin

Question

Difficulty: EasyGynecologic Infections

During a routine health maintenance visit, a 23-year-old female college student reports a bothersome change in her vaginal discharge over the past week. She describes the discharge as thin and grayish, accompanied by a noticeable malodor that is particularly prominent after sexual intercourse. She has no abdominal pain, pruritus, or dysuria. The patient has been in a monogamous relationship with a new male partner for the past month. Her temperature is 37.0°C (98.6°F) and blood pressure is 118/76 mm Hg. Abdominal examination is unremarkable. On pelvic examination, the vulva and vagina appear normal with no erythema, but a homogeneous, gray-white fluid smoothly coats the vaginal walls. The cervix appears normal, and there is no cervical motion tenderness. Vaginal pH is measured at 5.5. The addition of potassium hydroxide to the fluid produces a strong amine odor. Microscopic evaluation of a wet mount reveals multiple squamous epithelial cells with stippled appearances and indistinct borders. Which of the following is the most appropriate next step in management for this patient?

  1. Oral metronidazole for the patient onlyAnswer
  2. B
    Oral metronidazole for the patient and her male partner
  3. C
    Intramuscular ceftriaxone and oral doxycycline
  4. D
    Oral fluconazole
  5. E
    Oral azithromycin

Answer

The most appropriate next step is prescribing oral metronidazole for the patient only.
The correct answer is oral metronidazole for the patient only because the patient meets the classic Amsel criteria for bacterial vaginosis (BV), and current guidelines indicate that male partners of women with BV do not require treatment. BV is characterized by a shift in vaginal flora from Lactobacillus species to mixed anaerobes, and targeted therapy with metronidazole is highly effective.

Step-by-Step Solution

1
Evaluate the clinical presentation and physical exam findings.
The patient has a malodorous, thin, grayish vaginal discharge without signs of upper genital tract infection (no fever, abdominal pain, or cervical motion tenderness) or vulvovaginal inflammation (no erythema or pruritus).
To differentiate uncomplicated vaginitis from cervicitis or pelvic inflammatory disease.
2
Interpret the diagnostic point-of-care tests.
The findings meet all four Amsel criteria: homogeneous thin discharge, pH > 4.5 (measured at 5.5), positive whiff test (amine odor with KOH), and the presence of clue cells (squamous cells with indistinct borders) on microscopy.
Meeting at least three of the four Amsel criteria confirms the diagnosis of bacterial vaginosis (BV).
3
Determine the appropriate first-line pharmacotherapy.
Treatment consists of oral or intravaginal metronidazole or clindamycin for the patient only.
BV is caused by an overgrowth of anaerobic bacteria (e.g., Gardnerella vaginalis). Current guidelines recommend treating the symptomatic patient but specifically advise against treating male sexual partners, as studies show it does not reduce recurrence rates.

Key Concept

Bacterial vaginosis is diagnosed using Amsel criteria and is treated with metronidazole or clindamycin. Treatment of male sexual partners is not indicated.
Estimated Time:1m 0s
Rate this question

Topics

Gynecologic Infections

More questions from this topic